XML 80 R66.htm IDEA: XBRL DOCUMENT v2.4.1.9

14. Segment Reporting (Details) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Number Of Products And Services									8,000bio_NumberOfProductsAndServices
Net sales	$ 598,200,000us-gaap_SalesRevenueNet	$ 530,600,000us-gaap_SalesRevenueNet	$ 536,800,000us-gaap_SalesRevenueNet	$ 509,300,000us-gaap_SalesRevenueNet	$ 602,600,000us-gaap_SalesRevenueNet	$ 505,100,000us-gaap_SalesRevenueNet	$ 525,300,000us-gaap_SalesRevenueNet	$ 499,700,000us-gaap_SalesRevenueNet	$ 2,175,044,000us-gaap_SalesRevenueNet	$ 2,132,694,000us-gaap_SalesRevenueNet	$ 2,069,235,000us-gaap_SalesRevenueNet
Interest expense									22,131,000us-gaap_InterestExpense	61,271,000us-gaap_InterestExpense	51,112,000us-gaap_InterestExpense
Depreciation and amortization									149,900,000us-gaap_DepreciationDepletionAndAmortization	147,200,000us-gaap_DepreciationDepletionAndAmortization	130,400,000us-gaap_DepreciationDepletionAndAmortization
Segment profit									149,984,000us-gaap_OperatingIncomeLoss	169,456,000us-gaap_OperatingIncomeLoss	264,176,000us-gaap_OperatingIncomeLoss
Total assets	3,341,278,000us-gaap_Assets				3,388,790,000us-gaap_Assets				3,341,278,000us-gaap_Assets	3,388,790,000us-gaap_Assets
Payments to Acquire Property, Plant, and Equipment									120,999,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment	106,658,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment	142,869,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Life Science [Member]
Segment Reporting Information [Line Items]
Net sales									728,300,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	710,000,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	688,400,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Interest expense									5,500,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	10,400,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	13,400,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Depreciation and amortization									33,200,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	32,600,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	26,300,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Segment profit									(14,700,000)us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	(13,700,000)us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	13,200,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Total assets	361,500,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember				389,100,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember				361,500,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	389,100,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Payments to Acquire Property, Plant, and Equipment									14,100,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember	19,800,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = bio_LifeScienceMember
Clinical Diagnostics [Member]
Segment Reporting Information [Line Items]
Net sales									1,432,300,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	1,408,000,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	1,365,500,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Interest expense									15,900,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	30,100,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	37,800,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Depreciation and amortization									95,800,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	91,500,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	92,900,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Segment profit									167,100,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	176,200,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	202,600,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Total assets	884,900,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember				980,900,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember				884,900,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	980,900,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Payments to Acquire Property, Plant, and Equipment									60,100,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember	66,500,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
All Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales									14,400,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	14,700,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	15,300,000us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember
Interest expense									100,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	100,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	200,000us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember
Depreciation and amortization									0us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	100,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	100,000us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember
Segment profit									1,200,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	1,100,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	1,600,000us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember
Total assets	4,800,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember				5,100,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember				4,800,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	5,100,000us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember
Payments to Acquire Property, Plant, and Equipment									$ 0us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember	$ 200,000us-gaap_PaymentsToAcquirePropertyPlantAndEquipment / us-gaap_StatementBusinessSegmentsAxis = us-gaap_AllOtherSegmentsMember

X

- Definition

Number Of Products And Services

+ References

No definition available.

+ Details

Name:	bio_NumberOfProductsAndServices
Namespace Prefix:	bio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7



Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name:	us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

+ Details

Name:	us-gaap_InterestExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bio_ClinicalDiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bio_LifeScienceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: